APA (7th ed.) Citation

Tegethoff, J. F., Bischoff, R., Saleh, S., Blagojević, B., Merz, K., & Cheng, X. (2017). Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC. Molecules, 22(9), . https://doi.org/10.3390/molecules22091546

Chicago Style (17th ed.) Citation

Tegethoff, Jana F., Roland Bischoff, Sawsan Saleh, Biljana Blagojević, Karl-Heinz Merz, and Xinlai Cheng. "Methylisoindigo and Its Bromo-derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC." Molecules 22, no. 9 (2017). https://doi.org/10.3390/molecules22091546.

MLA (9th ed.) Citation

Tegethoff, Jana F., et al. "Methylisoindigo and Its Bromo-derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC." Molecules, vol. 22, no. 9, 2017, https://doi.org/10.3390/molecules22091546.